Annals of the Rheumatic Diseases: 82 (12)

Editorials

Lessons from negative phase 3 trials in rheumatoid arthritis anno 2023 (30 October, 2023) Free
René Westhovens, Patrick Verschueren
Time to treat the climate and nature crisis as one indivisible global health emergency (25 October, 2023)
Chris Zielinski

Viewpoint

Potential for biosimilars in rheumatology in Africa (19 July, 2023)
Mohamed Hassan Abu-Zaid, Adewale Adebajo, Yasser El Miedany

Review

Contributions of joint damage-related events to gout pathogenesis: new insights from laboratory research (16 August, 2023)
HanLin Xu, Hengwei Qin, YingHui Hua, Nicola Dalbeth

Rheumatoid arthritis

Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2) (12 September, 2023)
Roy M Fleischmann, Désirée van der Heijde, Vibeke Strand, Tatsuya Atsumi, Iain B McInnes, Tsutomu Takeuchi, Peter C Taylor, Marguerite Bracher, David Brooks, John Davies, Christopher Goode, Anubha Gupta, Sumanta Mukherjee, Ciara O’Shea, Didier Saurigny, Lorrie A Schifano, Celia Shelton, Julia E Smith, Millie Wang, Reena Wang, Sarah Watts, Michael E Weinblatt
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3) (11 September, 2023)
Peter C Taylor, Michael E Weinblatt, Iain B McInnes, Tatsuya Atsumi, Vibeke Strand, Tsutomu Takeuchi, Marguerite Bracher, David Brooks, John Davies, Christopher Goode, Anubha Gupta, Sumanta Mukherjee, Ciara O’Shea, Didier Saurigny, Lorrie A Schifano, Celia Shelton, Julia E Smith, Millie Wang, Reena Wang, Sarah Watts, Roy M Fleischmann

Early arthritis

Disease activity drives transcriptomic heterogeneity in early untreated rheumatoid synovitis (28 July, 2023)
Clément Triaille, Gaëlle Tilman, Tatiana Sokolova, Axelle Loriot, Joelle Marchandise, Stéphanie De Montjoye, Adrien Nzeusseu-Toukap, Laurent Méric de Bellefon, Caroline Bouzin, Christine Galant, Patrick Durez, Bernard R Lauwerys, Nisha Limaye
Directed differentiation of human pluripotent stem cells into articular cartilage reveals effects caused by absence of WISP3, the gene responsible for progressive pseudorheumatoid arthropathy of childhood
(7 September, 2023)
Chaochang Li, Mireia Alemany-Ribes, Rosanne M Raftery, Uzochi Nwoko, Matthew L Warman, April M Craft

Spondyloarthritis

HLA-B27, axial spondyloarthritis and survival (7 September, 2023) Free
Zhixiu Li, Mohammad Kazim Khan, Sjef M van der Linden, Bjorn Winkens, Peter M Villiger, Heinz Baumberger, Hermine van Zandwijk, Muhammad Asim Khan, Matthew A Brown

Systemic sclerosis

Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups (14 August, 2023)
Kristina Elizabeth Neergaard Clark, Shiwen Xu, Moustafa Attah, Voon H Ong, Christopher Dominic Buckley, Christopher P Denton

Vasculitis

Benralizumab for eosinophilic granulomatosis with polyangiitis (7 August, 2023)
Adrien Cottu, Matthieu Groh, Charlene Desaintjean, Sylvain Marchand-Adam, Loïc Guillevin, Xavier Puechal, Stacy Beaumesnil, Estibaliz Lazaro, Maxime Samson, Camille Taille, Cécile-Audrey Durel, Elizabeth Diot, Sarah Nicolas, Laurent Guilleminault, Mikael Ebbo, Pascal Cathebras, Clairelyne Dupin, Halil Yildiz, Nabil Belfeki, Grégory Pugnet, Pierre Chauvin, Stephane Jouneau, Francois Lifermann, Jean-Philippe Martellosio, Vincent Cottin, Benjamin Terrier
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study (21 September, 2023)
Berengere Molina, Roberto Padoan, Maria Letizia Urban, Pavel Novikov, Marco Caminati, Camille Taillé, Antoine Néel, Laurence Bouillet, Paolo Fraticelli, Nicolas Schleinitz, Christine Christides, Laura Moi, Bertrand Godeau, Ann Knight, Jan Walter Schroeder, Sylvain Marchand-Adam, Helder Gil, Vincent Cottin, Cécile-Audrey Durel, Elena Gelain, Boris Lerais, Marc Ruivard, Matthieu Groh, Maxime Samson, Luca Moroni, Jens Thiel, Anna Kernder, Jan Willem Cohen Tervaert, Giulia Costanzo, Marco Folci, Sonia Rizzello, Pascal Cohen, Giacomo Emmi, Benjamin Terrier

Autoinflammatory disorders

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
(4 September, 2023)
Jose Manuel Mascaro, Ignasi Rodriguez-Pinto, Gabriela Poza, Anna Mensa-Vilaro, Julian Fernandez-Martin, Luis Caminal-Montero, Gerard Espinosa, Jose Hernández-Rodríguez, Marina Diaz, Joana Rita-Marques, Raimon Sanmarti, Santos Castañeda, Dolores Colunga, Rubén Coto-Hernández, Patricia Fanlo, Jose Ignacio Elejalde, Segundo Bujan, Ignasi Figueras, Francisco Manuel Marco, Mariano Andrés, Silvia Suárez, Andres Gonzalez-Garcia, Xavier Fustà-Novell, Clara Garcia-Belando, Ana Granados, Maria Teresa Fernandez-Figueras, Neus Quilis, Maria Orriols-Caba, Ricardo Gómez de la Torre, Maria Cinta Cid, Georgina Espígol-Frigolé, Alba Alvarez-Abella, Eztizen Labrador, Maria Rozman, Monica Lopez-Guerra, Paola Castillo, Jose R Alamo-Moreno, Eva Gonzalez-Roca, Susana Plaza, Virginia Fabregat, Rocio Lara, Esther F Vicente-Rabaneda, Sonia Tejedor-Vaquero, Giuliana Magri, Nuria Bonet, Manuel Solis-Moruno, Andrea Cerutti, Oscar Fornas, Ferran Casals, Jordi Yagüe, Juan I Aróstegui

Osteoarthritis

Evaluating the causal effect of circulating proteome on the risk of osteoarthritis-related traits (18 August, 2023)
Yan Zhang, Jingyu Xie, Simin Wen, Peihua Cao, Wende Xiao, Jianwei Zhu, Shengfa Li, Zhiqiang Wang, Han Cen, Zhaohua Zhu, Changhai Ding, Guangfeng Ruan

Crystal arthropathies

Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink (3 October, 2023)
Edward Roddy, Ram Bajpai, Harry Forrester, Richard James Partington, Christian D Mallen, Lorna Elise Clarson, Nishita Padmanabhan, Rebecca Whittle, Sara Muller
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial (31 August, 2023)
Lisa Stamp, Anne Horne, Borislav Mihov, Jill Drake, Janine Haslett, Peter T Chapman, Christopher Frampton, Nicola Dalbeth

Images in rheumatology

Finger ischaemia, enlarged spleen and lung nodules (28 April, 2023)
Xavier Puéchal, Laure Delaval, Philippe Blanche

Letters

Low avidity observed for anti-citrullinated peptide antibody is not a general phenomenon for autoantibodies (10 July, 2023)
Hisakata Yamada, Akihisa Haraguchi, Tomomi Tsuru, Masakazu Kondo, Fumiaki Sagawa, Hiroaki Niiro, Yasuharu Nakashima
Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis (19 July, 2023)
Yoon Y Qiu, Tuhina Neogi, Lutfiyya N Muhammad, Jing Song, Marcy B Bolster, Wendy Marder, Andrew C Heisler, Alyssa Wohlfahrt, Dorothy Dunlop, Yvonne C Lee

EULAR news

News from EULAR (10 November, 2023) Free
EULAR Communications

Electronic pages

Correspondence on “Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry” by Machado et al
(11 July, 2022) Free
Rim Bourguiba, Marion Delplanque, Léa Savey, Veronique Hentgen, Gilles Grateau, Sophie Georgin-lavialle
Correspondence on “Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial” by Molto et al
(1 November, 2021) Free
Uta Kiltz, Juergen Braun
Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease’ by Wallace et al
(11 July, 2022) Free
Gözde Kübra Yardımcı, Beste Ekin Sandalcı Yıldırım, Bayram Farisoğulları, Levent Kilic, Omer Karadag
Correspondence on ‘NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus’ by Linge et al
(17 January, 2022) Free
George N Goulielmos, Maria I Zervou, Elias Eliopoulos

Main menu

Table of contents

December 2023 - Volume 82 - 12

Editorials

Viewpoint

Review

Rheumatoid arthritis

Early arthritis

Spondyloarthritis

Systemic sclerosis

Vasculitis

Autoinflammatory disorders

Osteoarthritis

Crystal arthropathies

Images in rheumatology

Letters

EULAR news

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

December 2023 - Volume 82 - 12

Editorials

Viewpoint

Review

Rheumatoid arthritis

Early arthritis

Spondyloarthritis

Systemic sclerosis

Vasculitis

Autoinflammatory disorders

Osteoarthritis

Crystal arthropathies

Images in rheumatology

Letters

EULAR news

Electronic pages

Issue Information